Erasca, Inc. Conversion of Stock, Amount Issued
Erasca, Inc. (ERAS) reported Conversion of Stock, Amount Issued of $340.80 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-23.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockAmountIssued1 · last filed 2023-03-23
- Erasca, Inc. conversion of stock, amount issued for the quarter ending 2021-12-31 was $0.00.
- Erasca, Inc. conversion of stock, amount issued for fiscal 2021 was $340.80M.
| Period end | Conversion of Stock, Amount Issued 3 month | Conversion of Stock, Amount Issued 9 month | Conversion of Stock, Amount Issued 12 month |
|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $340.80M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $340.80M 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |